common side effects of glyxambi
urinary tract infection
other side effects
increased ldl cholesterol
comprehensive list of adverse effects
linagliptin
postmarketing reports
rashdipeptidyl peptidase
inhibitors
postmarketing cases
bullous pemphigoid
postmarketing reports of bullous pemphigoid
requiring hospitalization
dpp
inhibitors
discontinuation of therapy
treatment with topical
systemic immunosuppressive agents
resolution
reported cases
pancreatitis
cases
patient year exposure in patients
receiving linagliptin
cases
patient year exposure in those
receiving active comparator
placebo
sulfonylurea
clinical trials
following
clinical trials
additional cases of pancreatitis
receiving linagliptin
postmarketing reports of acute pancreatitis
including fatalities
empagliflozin
nausealinagliptin
diarrheafrequency
pancreatitispostmarketing reports
acute pancreatitis
empagliflozin-linagliptin
urinary tract infection
postmarketing reports
urosepsis
pyelonephritisempagliflozin
urinary tract infection
female genital mycotic infections
urination
male genital mycotic infections
empagliflozin-linagliptin
frequency
increased hematocritempagliflozin
increased hematocrit
postmarketing
serious hypersensitivity reactions
angioedema
anaphylaxis
exfoliative skin conditions
patients
linagliptin
reactions
first months
first dose
linagliptin
frequency
hypersensitivity reactions
urticaria
angioedema
localized skin exfoliation
bronchial hyper-reactivitypostmarketing reports
serious hypersensitivity reactions
anaphylaxis
combination product
metformin therapy
overall incidence of hypoglycemia
patients
receiving empagliflozin mg-linagliptin mg
empagliflozin mg-linagliptin mg
reports of serious hypoglycemia
reports of acidosis
us food
drug administration
adverse event reporting system
faers
database during the period march through june
patients
emergency room treatment
hospitalization
cases
ketoacidosis
diabetic ketoacidosis
dka
patients with type diabetes
blood sugar levels
factors
triggering
acidosis
major illness
food
fluid intake
insulin dose
empagliflozin-linagliptin
hypoglycemia
cholesterolempagliflozin
increased low-density lipoprotein cholesterol
dyslipidemiapostmarketing reports
acidosis
diabetic ketoacidosis
ketoacidosis
ketosis linagliptin
increased uric acid
dipeptidyl peptidase
inhibitors
arthralgia-postmarketing cases
disabling arthralgia
october
december
cases of severe arthralgia
fda
adverse event reporting system database
case
use
more dipeptidyl peptidase
inhibitor
cases
substantial reduction in prior activity level
patients
disabling
disabling joint pain
cases
symptoms
month
starting therapy
cases symptoms
month after discontinuation
positive rechallenge
cases
cases
involving use of a different dpp
inhibitor
sitagliptin
greatest number of cases
n =-rrb-
saxagliptin
n =-rrb-
linagliptin
n =-rrb-
alogliptin
n =-rrb-
vildagliptin
n =-rrb-
postmarketing reports of aki
requiring hospitalization
dialysis
patients
sglt inhibitors
empagliflozin
reports
involved patients
years
empagliflozin
frequency
increased serum creatinine
egfrpostmarketing reports
acute kidney injury
aki
empagliflozin-linagliptin
nasopharyngitis
upper respiratory infectionempagliflozin
upper
respiratory infectionlinagliptin
nasopharyngitis
cough
bladder pain
cloudy urine
burning
painful urination
frequent urge
side pain
anxiety
bloating
blurred vision
chills
cold sweats
confusion
constipation
cool, pale skin
darkened urine
depression
dizziness
dry mouth
fast heartbeat
fever
flushed, dry skin
fruit-like breath odor
headache
increased hunger
increased thirst
indigestion
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
loss of appetite
loss of consciousness
nausea
nightmares
pains in the stomach
side
abdomen
radiating
back
seizures
severe joint pain
shakiness
slurred speech
stomach pain
sweating
troubled breathing
unexplained weight loss
unusual tiredness
weakness
vomiting
yellow eyes
skin
body aches
pain
difficulty with breathing
ear congestion
headache
loss of voice
stuffy nose
sneezing
sore throat
strong odor from the penis
redness
itching
swelling
pain around the penis
vaginal discharge
itching
odor